Related Experiment Video
Updated: Apr 10, 2026
MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues
Published on: November 30, 2013
MicroRNAs in Kidney Transplantation: Living up to Their Expectations?
Eline K van den Akker1, Frank J M F Dor1, Jan N M IJzermans1
1Department of Surgery, Erasmus MC University Medical Center, P.O. Box 2040, 3000 CA Rotterdam, Netherlands.
Abstract:
Since the discovery of microRNAs, ample research has been conducted to elucidate their involvement in an array of (patho)physiological conditions. Ischemia reperfusion injury is a major problem in kidney transplantation and its mechanism is still not fully known, nor is there an effective therapy. Furthermore, no biomarker is available to specifically measure (ischemic) damage after kidney transplantation or predict transplantation outcome. In this review, we summarize studies conducted on microRNAs in renal ischemia reperfusion injury and kidney transplantation. Although the number of publications on miRNAs in different areas of nephrology is increasing every year, only a limited number of reports that address the role of miRNAs in relation to ischemia reperfusion injury or kidney transplantation are available. All reports up to June 2014 on microRNAs in renal IRI, kidney transplantation, and renal allograft status were included. Design of the studies was highly variable and there was limited overlap between microRNAs found in these reports. No single microRNA expression pattern could be found, although multiple microRNAs involved in the immune response seem to be altered after ischemia reperfusion injury and kidney transplantation. Although there is a growing interest in microRNA research in kidney transplantation aiming to identify biomarkers and therapeutical targets, to date, no specific microRNA has been demonstrated to be applicable as either one, mostly because of lack of specificity. More systematical research is needed to determine whether microRNAs can be applied as biomarker, therapeutic target, or therapeutic agent in kidney transplantation.
Insights
MicroRNAs show potential in kidney transplantation research, but no specific biomarker exists yet. Further systematic studies are needed to explore microRNAs as diagnostic tools or therapeutic agents for ischemia reperfusion injury.
Area of Science:
- Nephrology
- Molecular Biology
- Transplantation Immunology
Background:
- Ischemia reperfusion injury (IRI) is a significant complication in kidney transplantation with unknown mechanisms and no effective therapies.
- Currently, no specific biomarkers exist to measure ischemic damage or predict outcomes after kidney transplantation.
- MicroRNAs (miRNAs) are increasingly recognized for their roles in various physiological and pathological conditions.
Purpose of the Study:
- To review existing literature on the role of microRNAs in renal ischemia reperfusion injury and kidney transplantation.
- To identify potential microRNA biomarkers or therapeutic targets for kidney transplantation.
- To assess the current limitations and future directions in microRNA research for kidney transplantation.
Main Methods:
- Systematic review of studies published up to June 2014.
- Inclusion criteria focused on microRNAs in renal IRI, kidney transplantation, and allograft status.
- Analysis of study designs and identified microRNAs across different reports.
Main Results:
- A limited number of studies investigate microRNAs in renal IRI and kidney transplantation.
- Significant variability in study designs and limited overlap in identified microRNAs were observed.
- While some microRNAs involved in immune responses appear altered, no specific expression pattern or single microRNA was consistently identified.
Conclusions:
- Despite growing interest, no specific microRNA has been validated as a biomarker or therapeutic target for kidney transplantation due to lack of specificity.
- MicroRNAs hold promise for diagnostics and therapeutics in kidney transplantation, but current evidence is insufficient.
- More systematic and rigorous research is essential to establish the clinical utility of microRNAs in kidney transplantation.
More Related Videos
07:01A Quantitative Detection Method for MicroRNAs in the Kidney of an Ischemic Kidney Injury Mouse Model
Published on: September 11, 2020
07:01Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models
Published on: May 10, 2022
Related Concept Videos
01:28Kidney Transplant I: Introduction
01:26Kidney Transplant II: Surgical Procedure
01:22MicroRNAs
01:22MicroRNAs
01:16Kidney Transplant III: Nursing Management